Pfizer has agreed to lower prescription drug costs for Medicaid and invest $70 billion in US manufacturing, President Donald Trump announced on Tuesday, in a move aimed at reducing healthcare costs. As of 1:26 PM (GMT-4), Pfizer shares were actively trading at $25.08, marking a sharp 5.14% gain, signaling strong investor interest and positive developments driving the surge. Trump made the announcement alongside Pfizer CEO Albert Bourla at the White House, highlighting the administration’s push to make medicines more affordable, AP reported. Under the deal, Pfizer will offer most-favoured-nation pricing to Medicaid, matching the lowest price available in other developed countries. The company will also guarantee that newly launched drugs follow the same pricing framework. “It’s

See Full Page